VivaVision reports positive data from Phase II dry eye disease trial
VivaVision Biotech has reported positive topline data from a Phase II clinical trial of VVN001 in dry eye disease patients.
Stay updated with breaking news from Key Challenges. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VivaVision Biotech has reported positive topline data from a Phase II clinical trial of VVN001 in dry eye disease patients.
BrainStorm is generating stem cells to test its ALS drug in a genetic subpopulation after missing the mark in a Phase III trial.
The Anywhere Workplace: Is Hybrid Work the Next Normal?
Experts were less keen on variant-specific vaccines versus Covid-19/flu combo due to lack of practical value, despite scientific rationale.
We've assembled a full guide on Super Nintendo World, so you can learn everything there is to know about the amazing Universal Studios area!